"Antibody Formation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
| Descriptor ID |
D000917
|
| MeSH Number(s) |
G12.070
|
| Concept/Terms |
Antibody Formation- Antibody Formation
- Formation, Antibody
- Antibody Response
- Antibody Responses
- Response, Antibody
- Responses, Antibody
- Antibody Production
- Production, Antibody
|
Below are MeSH descriptors whose meaning is more general than "Antibody Formation".
Below are MeSH descriptors whose meaning is more specific than "Antibody Formation".
This graph shows the total number of publications written about "Antibody Formation" by people in this website by year, and whether "Antibody Formation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 7 | 7 |
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 3 | 4 |
| 1998 | 3 | 2 | 5 |
| 1999 | 0 | 3 | 3 |
| 2000 | 2 | 7 | 9 |
| 2001 | 0 | 3 | 3 |
| 2002 | 1 | 4 | 5 |
| 2003 | 1 | 6 | 7 |
| 2004 | 2 | 7 | 9 |
| 2005 | 3 | 10 | 13 |
| 2006 | 1 | 7 | 8 |
| 2007 | 4 | 3 | 7 |
| 2008 | 2 | 7 | 9 |
| 2009 | 2 | 5 | 7 |
| 2010 | 1 | 2 | 3 |
| 2011 | 1 | 2 | 3 |
| 2012 | 3 | 5 | 8 |
| 2013 | 0 | 4 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 2 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 10 | 10 |
| 2022 | 2 | 4 | 6 |
| 2023 | 0 | 6 | 6 |
| 2024 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibody Formation" by people in Profiles.
-
Antibody Response to Symptomatic Infection With SARS-CoV-2 Omicron Variant Viruses, December 2021-June 2022. Influenza Other Respir Viruses. 2024 Jul; 18(7):e13339.
-
Waning immunity and IgG4 responses following bivalent mRNA boosting. Sci Adv. 2024 Feb 23; 10(8):eadj9945.
-
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis. 2024 01 25; 78(1):217-226.
-
Response to: regarding the significance of anti-COVID-IgA antibody response in COVID-19 breakthrough infection. Immunol Res. 2024 Jun; 72(3):366-367.
-
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines. Nat Commun. 2024 Jan 04; 15(1):254.
-
Significance of Anti-COVID-IgA antibody response in COVID-19 breakthrough infection in vaccinated patients - a single-centered study from Pakistan. Immunol Res. 2023 Dec; 71(6):941-949.
-
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses. Clin Infect Dis. 2023 05 24; 76(10):1822-1831.
-
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX?) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins (Basel). 2023 05 17; 15(5).
-
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypes. Cell Rep. 2023 04 25; 42(4):112370.
-
Convergent antibody responses are associated with broad neutralization of hepatitis C virus. Front Immunol. 2023; 14:1135841.